João L. Carapinha

AI Chatbot Delusions: Navigating the Risks of Validation in Mental Health

Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...

Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...

FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...

Navigating Novo Nordisk Board Changes: Leadership for Growth and Strategy

Fabhalta Kidney Treatment Shows Promise in Slowing Disease Progression for Ig...